Comments
Loading...

Teladoc Health Analyst Ratings

TDOCNYSE
Logo brought to you by Benzinga Data
$8.50
-0.06-0.70%
Pre-Market: 3:33 AM EDT
Consensus Rating1
Neutral
Highest Price Target1
$40.00
Lowest Price Target1
$8.00
Consensus Price Target1
$18.78

Teladoc Health Analyst Ratings and Price Targets | NYSE:TDOC | Benzinga

Teladoc Health Inc has a consensus price target of $18.78 based on the ratings of 33 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $8 issued by TD Cowen on October 31, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Piper Sandler, and Goldman Sachs on March 3, 2025, February 27, 2025, and February 18, 2025, respectively. With an average price target of $13.67 between Goldman Sachs, Piper Sandler, and Goldman Sachs, there's an implied 60.78% upside for Teladoc Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
2
2
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Piper Sandler
B of A Securities
RBC Capital
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Teladoc Health

Buy NowGet Alert
03/03/2025Buy Now52.94%Goldman Sachs
David Roman37%
$16 → $13MaintainsBuyGet Alert
02/27/2025Buy NowNeedham
Ryan MacDonald60%
ReiteratesHold → HoldGet Alert
02/27/2025Buy Now41.18%Piper Sandler
Jessica Tassan40%
$13 → $12MaintainsOverweightGet Alert
02/18/2025Buy Now88.24%Goldman Sachs
David Roman37%
$14 → $16MaintainsBuyGet Alert
02/12/2025Buy Now58.82%B of A Securities
Allen Lutz59%
$11.5 → $13.5MaintainsNeutralGet Alert
02/06/2025Buy Now35.29%B of A Securities
Allen Lutz59%
$10.5 → $11.5MaintainsNeutralGet Alert
01/24/2025Buy Now41.18%RBC Capital
Sean Dodge48%
$11 → $12MaintainsOutperformGet Alert
01/24/2025Buy Now41.18%Oppenheimer
Michael Wiederhorn61%
$14 → $12MaintainsOutperformGet Alert
12/04/2024Buy Now52.94%Piper Sandler
Jessica Tassan40%
$11 → $13ReiteratesOverweight → OverweightGet Alert
11/15/2024Buy Now64.71%Goldman Sachs
David Roman37%
→ $14Initiates → BuyGet Alert
11/01/2024Buy Now41.18%Deutsche Bank
George Hill62%
$10 → $12MaintainsHoldGet Alert
10/31/2024Buy Now41.18%Barclays
Steve Valiquette53%
$10 → $12MaintainsOverweightGet Alert
10/31/2024Buy Now-5.88%TD Cowen
Charles Rhyee37%
$9 → $8MaintainsHoldGet Alert
10/09/2024Buy Now17.65%RBC Capital
Sean Dodge48%
$9 → $10MaintainsOutperformGet Alert
10/08/2024Buy Now5.88%Evercore ISI Group
Elizabeth Anderson47%
$8 → $9MaintainsIn-LineGet Alert
09/17/2024Buy Now17.65%Jefferies
Glen Santangelo50%
$8 → $10MaintainsHoldGet Alert
08/26/2024Buy Now5.88%JP Morgan
Lisa Gill59%
$16 → $9MaintainsNeutralGet Alert
08/20/2024Buy Now17.65%Cantor Fitzgerald
Sarah James51%
$10 → $10ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy Now17.65%Piper Sandler
Jessica Tassan40%
$25 → $10MaintainsOverweightGet Alert
08/02/2024Buy Now17.65%Deutsche Bank
George Hill62%
$15 → $10MaintainsHoldGet Alert
08/02/2024Buy Now17.65%Truist Securities
Jailendra Singh38%
$15 → $10MaintainsHoldGet Alert
08/01/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
08/01/2024Buy Now5.88%TD Cowen
Charles Rhyee37%
$15 → $9MaintainsHoldGet Alert
08/01/2024Buy Now5.88%RBC Capital
Sean Dodge48%
$18 → $9MaintainsOutperformGet Alert
08/01/2024Buy Now17.65%Barclays
Steve Valiquette53%
$20 → $10MaintainsOverweightGet Alert
08/01/2024Buy Now5.88%Stifel
David Grossman63%
$16 → $9MaintainsHoldGet Alert
08/01/2024Buy Now-5.88%DA Davidson
Gil Luria59%
$12 → $8MaintainsNeutralGet Alert
08/01/2024Buy Now100%Canaccord Genuity
Richard Close47%
$25 → $17MaintainsBuyGet Alert
08/01/2024Buy Now100%Oppenheimer
Michael Wiederhorn61%
$21 → $17MaintainsOutperformGet Alert
07/09/2024Buy Now17.65%Evercore ISI Group
Elizabeth Anderson47%
$14 → $10MaintainsIn-LineGet Alert
05/21/2024Buy Now88.24%JP Morgan
Lisa Gill59%
$19 → $16MaintainsNeutralGet Alert
05/20/2024Buy Now64.71%Jefferies
Glen Santangelo50%
$16 → $14MaintainsHoldGet Alert
05/14/2024Buy Now58.82%B of A Securities
Allen Lutz59%
$16.5 → $13.5MaintainsNeutralGet Alert
04/29/2024Buy Now76.47%Wells Fargo
Stephen Baxter54%
$17 → $15MaintainsEqual-WeightGet Alert
04/26/2024Buy Now147.06%Oppenheimer
Michael Wiederhorn61%
$26 → $21MaintainsOutperformGet Alert
04/26/2024Buy Now76.47%TD Cowen
Charles Rhyee37%
$16 → $15MaintainsHoldGet Alert
04/26/2024Buy Now64.71%Evercore ISI Group$15 → $14MaintainsIn-LineGet Alert
04/26/2024Buy Now111.76%RBC Capital
Sean Dodge48%
$25 → $18MaintainsOutperformGet Alert
04/26/2024Buy Now88.24%Stifel
David Grossman63%
$21 → $16MaintainsHoldGet Alert
04/26/2024Buy Now135.29%Barclays
Steve Valiquette53%
$25 → $20MaintainsOverweightGet Alert
04/26/2024Buy Now194.12%Canaccord Genuity
Richard Close47%
$28 → $25MaintainsBuyGet Alert
04/26/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
04/05/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
03/06/2024Buy Now100%Truist Securities
Jailendra Singh38%
$23 → $17MaintainsHoldGet Alert
02/29/2024Buy Now158.82%Cantor Fitzgerald
Sarah James51%
→ $22Initiates → OverweightGet Alert
02/26/2024Buy Now100%Leerink Partners
Michael Cherny79%
→ $17Initiates → Market PerformGet Alert
02/21/2024Buy Now111.76%DA Davidson
Gil Luria59%
$22 → $18MaintainsNeutralGet Alert
02/21/2024Buy Now123.53%Citigroup
Daniel Grosslight42%
$21 → $19MaintainsNeutralGet Alert
02/21/2024Buy Now194.12%RBC Capital
Sean Dodge48%
$30 → $25MaintainsOutperformGet Alert
02/21/2024Buy Now194.12%Barclays
Steve Valiquette53%
$26 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now194.12%Piper Sandler
Jessica Tassan40%
$30 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now229.41%Canaccord Genuity
Richard Close47%
$34 → $28MaintainsBuyGet Alert
11/17/2023Buy Now123.53%JP Morgan
Lisa Gill59%
$33 → $19MaintainsNeutralGet Alert
10/25/2023Buy Now252.94%RBC Capital
Sean Dodge48%
$35 → $30MaintainsOutperformGet Alert
10/25/2023Buy Now205.88%Oppenheimer
Michael Wiederhorn61%
$35 → $26MaintainsOutperformGet Alert
10/23/2023Buy Now147.06%Citigroup
Daniel Grosslight42%
$29 → $21MaintainsNeutralGet Alert
10/20/2023Buy Now147.06%Citigroup
Daniel Grosslight42%
$29 → $21MaintainsNeutralGet Alert
09/25/2023Buy Now229.41%Truist Securities
Jailendra Singh38%
→ $28ReiteratesHold → HoldGet Alert
07/26/2023Buy Now229.41%Stephens & Co.
Jeff Garro37%
→ $28ReiteratesEqual-Weight → Equal-WeightGet Alert
07/26/2023Buy Now311.76%RBC Capital
Sean Dodge48%
→ $35ReiteratesOutperform → OutperformGet Alert
07/26/2023Buy Now241.18%Citigroup
Daniel Grosslight42%
$31 → $29MaintainsNeutralGet Alert
07/26/2023Buy Now217.65%Credit Suisse
Jonathan Yong64%
→ $27ReiteratesNeutral → NeutralGet Alert
04/28/2023Buy Now241.18%Deutsche Bank
George Hill62%
$27 → $29MaintainsHoldGet Alert
04/27/2023Buy Now264.71%Citigroup
Daniel Grosslight42%
$30 → $31MaintainsNeutralGet Alert
04/27/2023Buy Now311.76%RBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy Now217.65%Credit Suisse
Jonathan Yong64%
→ $27Reiterates → NeutralGet Alert
04/27/2023Buy Now241.18%Barclays
Steve Valiquette53%
$28 → $29MaintainsEqual-WeightGet Alert
04/12/2023Buy Now194.12%Stephens & Co.
Jeff Garro37%
→ $25Initiates → Equal-WeightGet Alert
03/10/2023Buy Now217.65%Credit Suisse
Jonathan Yong64%
$30 → $27MaintainsNeutralGet Alert
03/06/2023Buy Now323.53%Canaccord Genuity
Richard Close47%
$40 → $36MaintainsBuyGet Alert
03/06/2023Buy Now170.59%Wells Fargo
Stan Berenshteyn42%
$28 → $23MaintainsEqual-WeightGet Alert
02/28/2023Buy Now252.94%Citigroup
Daniel Grosslight42%
$33 → $30MaintainsNeutralGet Alert
02/27/2023Buy Now217.65%Deutsche Bank
George Hill62%
$31 → $27MaintainsHoldGet Alert
02/27/2023Buy Now288.24%JP Morgan
Lisa Gill59%
$35 → $33MaintainsNeutralGet Alert
02/23/2023Buy Now311.76%Oppenheimer
Michael Wiederhorn61%
$37 → $35MaintainsOutperformGet Alert
02/23/2023Buy Now311.76%RBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
02/23/2023Buy Now300%SVB Leerink
Stephanie Davis40%
→ $34UpgradeMarket Perform → OutperformGet Alert
01/19/2023Buy Now335.29%Oppenheimer
Colin Rusch55%
$45 → $37MaintainsOutperformGet Alert
01/18/2023Buy Now229.41%Barclays
Marc Solecitto63%
$32 → $28MaintainsEqual-WeightGet Alert
12/13/2022Buy Now288.24%Citigroup
Daniel Grosslight42%
$36 → $33MaintainsNeutralGet Alert
10/31/2022Buy Now252.94%Credit Suisse
Jonathan Yong64%
$35 → $30MaintainsNeutralGet Alert
10/27/2022Buy Now323.53%Citigroup
Daniel Grosslight42%
$38 → $36MaintainsNeutralGet Alert
10/27/2022Buy Now276.47%Barclays
Steve Valiquette53%
$33 → $32MaintainsEqual-WeightGet Alert
10/25/2022Buy Now370.59%DA Davidson
Robert Simmons54%
$45 → $40MaintainsBuyGet Alert
10/24/2022Buy NowGuggenheim
Sandy Draper72%
UpgradeSell → NeutralGet Alert
10/21/2022Buy Now241.18%Truist Securities
Jailendra Singh38%
$35 → $29MaintainsHoldGet Alert
10/11/2022Buy Now288.24%Barclays
Steve Valiquette53%
$40 → $33MaintainsEqual-WeightGet Alert
09/28/2022Buy Now311.76%RBC Capital
Sean Dodge48%
$53 → $35MaintainsOutperformGet Alert
09/27/2022Buy Now264.71%Deutsche Bank
George Hill62%
$34 → $31MaintainsHoldGet Alert
09/16/2022Buy NowKeybanc
Scott Schoenhaus44%
Initiates → Sector WeightGet Alert
09/07/2022Buy Now311.76%Truist Securities
Jailendra Singh38%
→ $35Initiates → HoldGet Alert
08/17/2022Buy Now194.12%Guggenheim
Sandy Draper72%
→ $25DowngradeNeutral → SellGet Alert
08/12/2022Buy Now429.41%DA Davidson
Robert Simmons54%
→ $45Initiates → BuyGet Alert
08/02/2022Buy Now311.76%Berenberg
Ravi Misra33%
$42 → $35DowngradeBuy → HoldGet Alert
08/02/2022Buy Now300%Cowen & Co.
Charles Rhyee37%
$58 → $34DowngradeOutperform → Market PerformGet Alert
07/28/2022Buy Now323.53%Goldman Sachs
Cindy Motz28%
$55 → $36DowngradeBuy → NeutralGet Alert
07/28/2022Buy Now370.59%Barclays
Steve Valiquette53%
$42 → $40MaintainsEqual-WeightGet Alert
07/28/2022Buy NowNeedham
Ryan MacDonald60%
DowngradeBuy → HoldGet Alert
07/28/2022Buy Now370.59%Piper Sandler
Jessica Tassan40%
$42 → $40MaintainsOverweightGet Alert
07/28/2022Buy Now547.06%Oppenheimer
Michael Wiederhorn61%
$65 → $55MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Teladoc Health (TDOC) stock?

A

The latest price target for Teladoc Health (NYSE:TDOC) was reported by Goldman Sachs on March 3, 2025. The analyst firm set a price target for $13.00 expecting TDOC to rise to within 12 months (a possible 52.94% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teladoc Health (TDOC)?

A

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by Goldman Sachs, and Teladoc Health maintained their buy rating.

Q

When was the last upgrade for Teladoc Health (TDOC)?

A

The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.

Q

When was the last downgrade for Teladoc Health (TDOC)?

A

The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.

Q

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.

Q

Is the Analyst Rating Teladoc Health (TDOC) correct?

A

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $16.00 to $13.00. The current price Teladoc Health (TDOC) is trading at is $8.50, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch